Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
RISE: Remote Intervention for Strength Training in Endometrial Cancer
Sponsor: Mayo Clinic
A NA clinical study on FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma and FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, this trial is ongoing. The trial is conducted by Mayo Clinic and has accumulated 7 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2024 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Feb 2024 — Apr 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .